相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The PERK Pathway Plays a Neuroprotective Role During the Early Phase of Secondary Brain Injury Induced by Experimental Intracerebral Hemorrhage
Juyi Zhang et al.
SUBARACHNOID HEMORRHAGE: NEUROLOGICAL CARE AND PROTECTION (2020)
CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma
Zongyi Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
D. Allan Butterfield et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico et al.
REDOX BIOLOGY (2019)
Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome
Ping Jun Zhu et al.
SCIENCE (2019)
Activation of Nrf2/ARE pathway alleviates the cognitive deficits in PS1V97L-Tg mouse model of Alzheimer's disease through modulation of oxidative stress
Yuanruhua Tian et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2019)
Tau drives translational selectivity by interacting with ribosomal proteins
Shon A. Koren et al.
ACTA NEUROPATHOLOGICA (2019)
Nrf2 stabilization prevents critical oxidative damage in Down syndrome cells
Emiliano Zamponi et al.
AGING CELL (2018)
The Vici syndrome protein EPG5 regulates intracellular nucleic acid trafficking linking autophagy to innate and adaptive immunity
E. Piano Mortari et al.
AUTOPHAGY (2018)
mTOR in Down syndrome: Role in A beta and tau neuropathology and transition to Alzheimer disease-like dementia
Fabio Di Domenico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models
Chiara Lanzillotta et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease
Gabriela Mercado et al.
NEUROBIOLOGY OF DISEASE (2018)
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy
Ana Rojo et al.
REDOX BIOLOGY (2018)
Aging-related decline in the induction of Nrf2-regulated antioxidant genes in human bronchial epithelial cells
Lulu Zhou et al.
REDOX BIOLOGY (2018)
Bach1: Function, Regulation, and Involvement in Disease
Xinyue Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Antonella Tramutola et al.
TRANSLATIONAL NEURODEGENERATION (2018)
The role of endoplasmic reticulum stress in neurodegenerative disease
Chunchen Xiang et al.
APOPTOSIS (2017)
Down syndrome and the complexity of genome dosage imbalance
Stylianos E. Antonarakis
NATURE REVIEWS GENETICS (2017)
Fine-tuning PERK signaling for neuroprotection
Mark Halliday et al.
JOURNAL OF NEUROCHEMISTRY (2017)
ER stress and the unfolded protein response in neurodegeneration
Claudio Hetz et al.
NATURE REVIEWS NEUROLOGY (2017)
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome
Vincenzo Roncace et al.
NEUROBIOLOGY OF DISEASE (2017)
Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation
Dongdong Sun et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Andrea Contestabile et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
The burden of trisomy 21 disrupts the proteostasis network in Down syndrome
Stefanos Aivazidis et al.
PLOS ONE (2017)
When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157
Diego Rojas-Rivera et al.
CELL DEATH AND DIFFERENTIATION (2017)
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics
Fabio Di Domenico et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology
Antonella Tramutola et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Elizabeth Head et al.
CURRENT ALZHEIMER RESEARCH (2016)
The unfolded protein response: mechanisms and therapy of neurodegeneration
Heather L. Smith et al.
BRAIN (2016)
PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration
Michelle C. Bell et al.
CURRENT ALZHEIMER RESEARCH (2016)
Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype
Antonella Tramutola et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis
Shelby Meier et al.
JOURNAL OF NEUROSCIENCE (2016)
AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550
Min Sung Joo et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Ageing, neurodegeneration and brain rejuvenation
Tony Wyss-Coray
NATURE (2016)
Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease
Wenzhong Yang et al.
NEUROBIOLOGY OF AGING (2016)
The unfolded protein response in neurodegenerative diseases: a neuropathological perspective
Wiep Scheper et al.
ACTA NEUROPATHOLOGICA (2015)
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia
Helois Radford et al.
ACTA NEUROPATHOLOGICA (2015)
Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics
Aaron M. Swomley et al.
ARCHIVES OF TOXICOLOGY (2015)
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD
Antonella Tramutola et al.
JOURNAL OF NEUROCHEMISTRY (2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Quercetin reduces eIF2α phosphorylation by GADD34 induction
Miki Hayakawa et al.
NEUROBIOLOGY OF AGING (2015)
Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1/BVR-A System: Insights for Transition to Alzheimer's Disease
Fabio Di Domenico et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
D. Allan Butterfield et al.
BIOCHEMICAL JOURNAL (2014)
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
Marzia Perluigi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease
Fabio Di Domenico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression
Mimi A. Trinh et al.
LEARNING & MEMORY (2014)
Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes
Mohammed Mahidur Rahman et al.
AGING CELL (2013)
Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: Redox proteomics analysis of human brain
Fabio Di Domenico et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Systemic oxidative stress in children and teenagers with Down syndrome
Thais Regina Garlet et al.
LIFE SCIENCES (2013)
Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits
Tao Ma et al.
NATURE NEUROSCIENCE (2013)
A New PERKspective on Neurodegeneration
Wiep Scheper et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
Julie A. Moreno et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
Giovanna Cenini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Oxidative Stress and Memory Decline in Adults with Down Syndrome: Longitudinal Study
Panagiotis Zis et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
Jeffrey M. Axten et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Sustained translational repression by eIF2α-P mediates prion neurodegeneration
Julie A. Moreno et al.
NATURE (2012)
Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn
Laura G. Reinholdt et al.
MAMMALIAN GENOME (2011)
Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid
Marzia Perluigi et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Peter Walter et al.
SCIENCE (2011)
Phosphorylation Dynamics Regulate Hsp27-Mediated Rescue of Neuronal Plasticity Deficits in Tau Transgenic Mice
Jose F. Abisambra et al.
JOURNAL OF NEUROSCIENCE (2010)
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract
Malin von Otter et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics
Christopher D. Aluise et al.
NEUROBIOLOGY OF DISEASE (2010)
The Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Jeroen J. M. Hoozemans et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia
T. Toki et al.
LEUKEMIA (2009)
Divergent Effects of PERK and IRE1 Signaling on Cell Viability
Jonathan H. Lin et al.
PLOS ONE (2009)
The four ages of Down syndrome
Alan H. Bittles et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2007)
Expression of Nrf2 in neurodegenerative diseases
Chenere P. Ramsey et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
A guided tour into subcellular colocalization analysis in light microscopy
S. Bolte et al.
JOURNAL OF MICROSCOPY (2006)
Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo
Ursula Unterberger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway
SB Cullinan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
The unfolded protein response is activated in Alzheimer's disease
JJM Hoozemans et al.
ACTA NEUROPATHOLOGICA (2005)
Alzheimer disease and Down syndrome: factors in pathogenesis
IT Lott et al.
NEUROBIOLOGY OF AGING (2005)
Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid
JH Suh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2
PD Lu et al.
EMBO JOURNAL (2004)
Activating transcription factor 4 is translationally regulated by hypoxic stress
JD Blais et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress
SB Cullinan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene-dosage effects in Down syndrome and trisomic mouse models
K Gardiner
GENOME BIOLOGY (2004)
Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival
SB Cullinan et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress
YJ Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress - elucidation by GADD34-deficient mice
E Kojima et al.
FASEB JOURNAL (2003)
Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2α in neuronal degeneration
RCC Chang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The changing survival profile of people with Down's syndrome: implications for genetic counselling
EJ Glasson et al.
CLINICAL GENETICS (2002)
Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse
MN Gordon et al.
EXPERIMENTAL NEUROLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α
I Novoa et al.
JOURNAL OF CELL BIOLOGY (2001)
Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2
HC Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
